Susan Mahony - 10 Oct 2023 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Nick Pizzie, Attorney-in-Fact
Issuer symbol
AXSM
Transactions as of
10 Oct 2023
Net transactions value
$0
Form type
4
Filing time
12 Oct 2023, 20:33:45 UTC
Previous filing
06 Oct 2023
Next filing
08 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +1,502 $0.000000 1,502 10 Oct 2023 Common Stock 1,502 $70.56 Direct F1
transaction AXSM Stock Option (Right to Buy) Award $0 +5,873 $0.000000 5,873 10 Oct 2023 Common Stock 5,873 $70.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the one-year anniversary of the date of grant, October 10, 2024.
F2 The option will vest in equal annual installments over three years such that the option will be fully vested on October 10, 2026.